Table 1. Pd-Catalyzed C-H Activation of Caffeine (1a) with Benzene (2a)a
entry
Pd(OAc)2 (mol %)
oxidant
PivOH (equiv)
yield of 3a (%)
1
2
10
10
10
15
20
30
Ag2CO3 (3 equiv); Ar
Ag2CO3 (3 equiv); O2
Ag2CO3 (3 equiv); O2
Ag2CO3 (3 equiv); O2
Ag2CO3 (3 equiv); O2
Ag2CO3 (3 equiv); O2
Ag2CO3 (3 equiv); O2
10
21
41
46
56
75
3
3
3
3
3
3
3
4
5
6
7
8
10
trace
20b
17c
8d
9
2.5
10
Cu(OAc)2 H2O (1.5 equiv); Ar
3
10
11
Cu(OAc)2 (2 equiv); Ar
Ag2CO3 (1.5 equiv); Ar
1.5
2.5
a All reactions were performed with 0.5 mmol of 1a and 20 mmol of 2a in a sealed vial, unless otherwise indicated. b Reaction was carried out with 1 equiv of
pyridine as an additive at 120 °C for 20 h in 0.6 mL of 1,4-dioxane. c In a sealed vial, 0.2 mmol of 1a was reacted with 22.4 mmol of 2a, using 0.75 equiv of Na2CO3 at
110 °C for 24 h in 2 mL of DMA. d Reaction was carried out with 1 equiv of AcOH at 120 °C for 7 h in 2 mL of DMF and 100 μL (5%) of DMSO.
the groups of Fagnou7 and DeBoef,8 who demonstrated
that indoles and benzofurans can be coupled with arenes.
Although intermolecular cross-coupling has been ex-
tended to intermolecular (hetero)arylations of pyrrols,7b
pyridin-N-oxides,9 anilides,10 benzo[h]quinolines,11 N-
acetyl tetrahydroquinolines,12 and perfluoroarenes,13 the
range of substrates that can be cross-coupled remains
small.
Xanthines such as caffeine, theophilline, and theobro-
mine are important biologically active alkaloids. In the
field of medicinal chemistry, C-8 (hetero)aryl-substituted
xanthines are of considerable interest as they are known to
act as selective antagonists of the human A2B adenosine
receptor.14 By using the classic methods repertoire of
heterocyclic chemistry the synthesis of C-8 arylated
xanthines can only be achieved by multistep synthesis of
the xanthine skeleton itself. And therefore, a modular,
straightforward approach allowing for the synthesis of C-8
arylated xanthines in a single step is highly desirable, which
iswhy considerableefforthas been devoted tothe arylation
of xanthines over the past few years. Recently, Daugulis15
and You16 have developed the Pd- and the Cu-catalyzed
C-8 arylation of xanthines, respectively, by using aryl
halides as coupling partners, while Ackermann reported
on similar reactions using the corresponding aryl tosylates
as substrates.17 The use of arylboronic acids for the aryla-
tion of xanthines has also been described.18 Recently, the
direct heteroarylation of xanthines with thiophenes and
furans has been achieved.19 The direct arylation of
xanthines, however, has not been achieved so far.
Here we disclose that C-8 arylated xanthines can be
efficiently synthesized via Pd-catalyzed double C-H acti-
vation of unactivated xanthines with unactivated arenes.
The starting point of our study (Table 1) was the
observation that the reaction of caffeine (1a) and benzene
(2a) performed in the presence of 10 mol % of Pd(OAc)2 as
a catalyst, Ag2CO3 as an oxidant, and under an atmo-
sphere of Ar led to the exclusive isolation of the cross-
coupling product 8-phenylxanthine (3a) with 10% yield
(Table 1, entry 1). Remarkably, the yield of the product 3a
could be doubled to 21% by replacing Ar with O2 (Table 1,
entry 2). When pivalic acid was added (Table 1, entry 3)
8-phenylxanthine (3a) was formed in 41% yield. Other
(8) (a) Dwight, T. A.; Rue, N. R.; Charyk, D.; Josselyn, R.; DeBoef,
B. Org. Lett. 2007, 9, 3137–3139. (b) Potavathri, S.; Dumas, A. S.;
Dwight, T. A.; Naumiec, G. R.; Hammann, J. M.; DeBoef, B. Tetra-
hedron Lett. 2008, 49, 4050–4053. (c) Potavathri, S.; Pereira, K. C.;
Gorelsky, S. I.; Pike, A.; LeBris, A. P.; DeBoef, B. J. Am. Chem. Soc.
2010, 132, 14676–14681.
(9) Cho, S. H.; Hwang, S. J.; Chang, S. J. Am. Chem. Soc. 2008, 130,
9254–9256.
(10) Brasche, G.; Garcia-Fortanet, J.; Buchwald, S. L. Org. Lett.
2008, 10, 2207–2210.
(11) Hull, K. L.; Sanford, M. S. J. Am. Chem. Soc. 2007, 129, 11904–
11905.
(15) Chiong, H. A.; Daugulis, O. Org. Lett. 2007, 9, 1449–1451.
(16) (a) Zhao, D.; Wang, W.; Yang, F.; Lan, J.; Yang, L.; Gao, G.;
You, J. Angew. Chem., Int. Ed. 2009, 48, 3296–3300. (b) Zhao, D.; Wang,
W.; Lian, S.; Yang, F.; Lan, J.; You, J. Chem.;Eur. J. 2009, 15, 1337–
1340.
(12) Li, B.-J.; Tian, S.-L.; Fang, Z.; Shi, Z.-J. Angew. Chem., Int. Ed.
2008, 47, 1115–1118.
(13) (a) Wei, Y.; Su, W. J. Am. Chem. Soc. 2010, 132, 16377–16379.
(b) He, C.-Y.; Fan, S.; Zhang, X. J. Am. Chem. Soc. 2010, 132, 12850–
12852.
(17) Ackermann, L.; Althammer, A.; Fenner, S. Angew. Chem., Int.
Ed. 2009, 48, 201–204.
(18) Liu, B.; Qin, X.; Li, K.; Li, X.; Guo, Q.; Lan, J.; You, J. Chem.;
Eur. J. 2010, 16, 11836–11839.
(19) Xi, P.; Yang, F.; Qin, S.; Zhao, D.; Lan, J.; Gao, G.; Hu, C.;
You, J. J. Am. Chem. Soc. 2010, 132, 1822–1824.
(14) (a) Hayallah, A. M.; Sandoval-Ramırez, J.; Reith, U.; Schobert,
´
€
2002, 45, 1500–1510. (b) Yan, L.; Muller, C. E. J. Med. Chem. 2004, 47,
1031–1043. (c) Kalla, R. V.; Elzein, E.; Perry, T.; Li, X.; Palle, V.;
Varkhedkar, V.; Gimbel, A.; Maa, T.; Zeng, D.; Zablocki, J. J. Med.
Chem. 2006, 49, 3682–3692.
U.; Preiss, B.; Schumacher, B.; Daly, J. W.; Muller, C. E. J. Med. Chem.
€
Org. Lett., Vol. 13, No. 6, 2011
1379